Congestion and sleep impairment in allergic rhinitis

Niti Sardana, Timothy J. Craig

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Allergic rhinitis is a disease with an increasing prevalence throughout the world that severely affects the quality of life of individuals suffering from it. Nasal congestion is the most common and bothersome symptom, and is often associated with sleep-disordered breathing, which is thought to be the reason for sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

Original languageEnglish (US)
Pages (from-to)297-306
Number of pages10
JournalAsian Pacific Journal of Allergy and Immunology
Volume29
Issue number4
StatePublished - Dec 1 2011

Fingerprint

Sleep
Nose
Quality of Life
montelukast
Adrenal Cortex Hormones
Sleep Apnea Syndromes
Rhinitis
Fatigue
Allergic Rhinitis
Therapeutics
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

@article{ea9c86793d5d45b49d08e57a5bc7e725,
title = "Congestion and sleep impairment in allergic rhinitis",
abstract = "Allergic rhinitis is a disease with an increasing prevalence throughout the world that severely affects the quality of life of individuals suffering from it. Nasal congestion is the most common and bothersome symptom, and is often associated with sleep-disordered breathing, which is thought to be the reason for sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.",
author = "Niti Sardana and Craig, {Timothy J.}",
year = "2011",
month = "12",
day = "1",
language = "English (US)",
volume = "29",
pages = "297--306",
journal = "Asian Pacific Journal of Allergy and Immunology",
issn = "0125-877X",
publisher = "The Allergy and Immunology Society of Thailand",
number = "4",

}

Congestion and sleep impairment in allergic rhinitis. / Sardana, Niti; Craig, Timothy J.

In: Asian Pacific Journal of Allergy and Immunology, Vol. 29, No. 4, 01.12.2011, p. 297-306.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Congestion and sleep impairment in allergic rhinitis

AU - Sardana, Niti

AU - Craig, Timothy J.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Allergic rhinitis is a disease with an increasing prevalence throughout the world that severely affects the quality of life of individuals suffering from it. Nasal congestion is the most common and bothersome symptom, and is often associated with sleep-disordered breathing, which is thought to be the reason for sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

AB - Allergic rhinitis is a disease with an increasing prevalence throughout the world that severely affects the quality of life of individuals suffering from it. Nasal congestion is the most common and bothersome symptom, and is often associated with sleep-disordered breathing, which is thought to be the reason for sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

UR - http://www.scopus.com/inward/record.url?scp=84855251937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855251937&partnerID=8YFLogxK

M3 - Article

C2 - 22299308

AN - SCOPUS:84855251937

VL - 29

SP - 297

EP - 306

JO - Asian Pacific Journal of Allergy and Immunology

JF - Asian Pacific Journal of Allergy and Immunology

SN - 0125-877X

IS - 4

ER -